Phytofabricated zinc oxide nanoparticles from Celosia argentea L.: mechanistic insights into ROS-mediated apoptosis in the MCF-7 cell line and photocatalytic degradation of malachite green
TL;DR
The results suggest that plant-mediated ZnO NPs could be useful as anticancer agents, though further studies are needed in other cancer cell lines, with normal cells as controls, and in in vivo models.
Abstract
The green synthetic approach of nanoparticle synthesis using medicinal plants has emerged as an eco-friendly and efficient approach to develop novel therapeutic agents against cancer. In the present study, zinc oxide nanoparticles (ZnO NPs) were synthesized using methanolic flower extract of Celosia argentea L., a plant known for its rich phytochemical composition and pharmacological properties. The biosynthesized ZnO NPs were characterized using UV–Vis spectroscopy, FTIR, XRD, and SEM analyses. The antioxidant activity of the extract and ZnO NPs was assessed using DPPH, ABTS, FRAP, superoxide scavenging, and metal-chelation assays. Cytotoxicity against MCF-7 cells was evaluated by MTT assay. Apoptotic features were examined by DAPI/confocal microscopy, and ROS levels and apoptotic cell percentages were analyzed by flow cytometry. Expression of apoptosis-related proteins was assessed by Western blotting. Visible light-driven photocatalytic activity was tested against Malachite Green (MG) under varying dye concentration, catalyst loading, and pH, and degradation kinetics, reusability over five consecutive cycles, and radical-scavenging assays were also evaluated. The analyses confirmed the crystalline nature, nanoscale size, and phytochemical capping of the ZnO NPs. TEM analysis revealed an average apparent particle size of 18.76 nm, whereas Williamson–Hall analysis of the XRD data estimated a crystallite size of 28.83 nm. The extract exhibited concentration-dependent antioxidant activity in all assays, and ZnO NPs were more active than the extract in all assays. The MTT assay showed dose-dependent cytotoxic effects of the extract (CAFE) and ZnO NPs against MCF-7 cells, with GI50 values of 32.71 and 8.735 µg/mL, respectively, at 24 hours. DAPI/confocal microscopy revealed chromatin condensation, nuclear fragmentation, membrane blebbing, and apoptotic bodies. Flow cytometry showed increased ROS levels and percentage of apoptotic cells after treatment. Western blotting showed enhanced expression of p53, caspase-3, and caspase-9 and reduced expression of Bcl-xl, indicating induction of apoptosis. Under optimized conditions (initial dye concentration of 10 ppm, catalyst loading of 20 mg, pH 9), the ZnO NPs achieved 99.62% degradation of MG within 60 min under visible light. Degradation efficiency decreased with increasing dye concentration, whereas alkaline conditions and higher catalyst loading favored performance. The process followed pseudo-first-order kinetics, with the highest apparent rate constant (k₁ = 0.061 min⁻¹; R ² = 0.99) at 10 ppm MG. The ZnO NPs retained substantial photocatalytic activity after five consecutive cycles. Radical-scavenging assays revealed that superoxide radicals (O₂•⁻) played the predominant role, while hydroxyl radicals and photogenerated holes contributed to the overall oxidative degradation. In general, C. argentea -mediated ZnO NPs induce ROS-mediated apoptosis through regulation of apoptosis-related proteins in MCF-7 cells. These results suggest that plant-mediated ZnO NPs could be useful as anticancer agents, though further studies are needed in other cancer cell lines, with normal cells as controls, and in in vivo models. The phytofabricated ZnO NPs also show strong potential as reusable visible-light photocatalysts for dye degradation.